Nov. 3, 2009 (PR Newswire) --
BOTHELL, Wash., Nov. 3 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced it will present at the Third Annual Canaccord Adams Cardiovascular Conference at the Nikko Hotel in San Francisco. Dave Marver, president and chief executive officer, will review the Company's business strategy and recent financial results during the Company's presentation on Tuesday, November 10, 2009 at 10:00 a.m. Pacific Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)
Attendance at the conference is by invitation only. Cardiac Science will offer a live Web cast of its presentation, accessible at http://cardiacscience.com. An archived replay of the presentation will also be available following the live presentation at http://cardiacscience.com for 60 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, vital signs monitors, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.
For more information,
Cardiac Science Contact: Investor Contact: Media Contact:
Mike Matysik Matt Clawson Christopher Gale
Cardiac Science Corporation Allen & Caron EVC Group Inc.
Senior Vice President and CFO 949.474.4300 646.201.5431
425.402.2009 matt@allencaron.com 203.570.4681
cgale@evcgroup.com
CSCX-F
SOURCE Cardiac Science Corporation
